Log In
BCIQ
Print this Print this
 

LK-2

  Manage Alerts
Collapse Summary General Information
Company Lykera Biomed S.A.
DescriptionArginine-glycine-aspartic acid (RGD) peptide
Molecular Target
Mechanism of ActionIntegrin alpha(5)beta(3) antagonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today